Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kavanagh

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
JMIR Mental Health|December 6, 2024
The Use of a Digital Well-Being App (Stay Strong App) With Indigenous People in Prison: Randomized Controlled TrialElke Perdacher, David Kavanagh, Jeanie Sheffield, et al.
Journal of Foot and Ankle Research|February 11, 2021
Effects of training podiatrists to use imagery-based motivational interviewing when treating people with diabetes-related foot disease: a mixed-methods pilot studyTracey Kaczmarek, Jaap J Van Netten, Peter A Lazzarini, et al.
Clinical Psychology & Psychotherapy|November 29, 2013
A randomized controlled trial of a correspondence-based intervention for carers of relatives with psychosisFrank P Deane, Sarah Marshall, Trevor Crowe, et al.
Internet Interventions|March 14, 2017
People trying to lose weight dislike calorie counting apps and want motivational support to help them achieve their goalsLinda Solbrig, Ray Jones, David Kavanagh, et al.
Addictive Behaviors|December 23, 2008
Impulsivity and positive psychotic symptoms influence hostility in methamphetamine usersKely Lapworth, Sharon Dawe, Penelope Davis, et al.
The Cochrane Database of Systematic Reviews|March 30, 2021
Interventions for atypical haemolytic uraemic syndromeDan Pugh, Eoin D O'Sullivan, Fiona Ai Duthie, et al.
JMIR Formative Research|April 8, 2022
Using the Stay Strong App for the Well-being of Indigenous Australian Prisoners: Feasibility StudyElke Perdacher, David Kavanagh, Jeanie Sheffield, et al.
Nephron. Clinical Practice|July 16, 2005
Risk factors for restless legs syndrome in dialysis patientsSamira Siddiqui, David Kavanagh, Jamie Traynor, et al.
Molecular Immunology|August 20, 2018
Developments in anti-complement therapy; from disease to clinical trialClaire L Harris, Richard B Pouw, David Kavanagh, et al.
The Journal of Biological Chemistry|January 29, 2011
Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activitiesIsabell C Pechtl, David Kavanagh, Nicola McIntosh, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
JMIR Mental Health|December 6, 2024
The Use of a Digital Well-Being App (Stay Strong App) With Indigenous People in Prison: Randomized Controlled TrialElke Perdacher, David Kavanagh, Jeanie Sheffield, et al.
Journal of Foot and Ankle Research|February 11, 2021
Effects of training podiatrists to use imagery-based motivational interviewing when treating people with diabetes-related foot disease: a mixed-methods pilot studyTracey Kaczmarek, Jaap J Van Netten, Peter A Lazzarini, et al.
Clinical Psychology & Psychotherapy|November 29, 2013
A randomized controlled trial of a correspondence-based intervention for carers of relatives with psychosisFrank P Deane, Sarah Marshall, Trevor Crowe, et al.
Internet Interventions|March 14, 2017
People trying to lose weight dislike calorie counting apps and want motivational support to help them achieve their goalsLinda Solbrig, Ray Jones, David Kavanagh, et al.
Addictive Behaviors|December 23, 2008
Impulsivity and positive psychotic symptoms influence hostility in methamphetamine usersKely Lapworth, Sharon Dawe, Penelope Davis, et al.
The Cochrane Database of Systematic Reviews|March 30, 2021
Interventions for atypical haemolytic uraemic syndromeDan Pugh, Eoin D O'Sullivan, Fiona Ai Duthie, et al.
JMIR Formative Research|April 8, 2022
Using the Stay Strong App for the Well-being of Indigenous Australian Prisoners: Feasibility StudyElke Perdacher, David Kavanagh, Jeanie Sheffield, et al.
Nephron. Clinical Practice|July 16, 2005
Risk factors for restless legs syndrome in dialysis patientsSamira Siddiqui, David Kavanagh, Jamie Traynor, et al.
Molecular Immunology|August 20, 2018
Developments in anti-complement therapy; from disease to clinical trialClaire L Harris, Richard B Pouw, David Kavanagh, et al.
The Journal of Biological Chemistry|January 29, 2011
Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activitiesIsabell C Pechtl, David Kavanagh, Nicola McIntosh, et al.
Pageof 20